Stock Market

Stock Market

Lilly’s Zepbound weight loss therapy becomes the first FDA-approved drug for sleep apnea

Author: Bhanvi Satiya (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's (NYSE:) weight loss drug Zepbound for obstructive sleep apnea, making it the first drug to get the green lightweight to directly treat patients with the common sleep disorder. Regulatory approval of...
Read more
abcd
Load more
sadasda

Find us on

Latest articles

- Advertisement -
abcd

Trader News is a Professional Blog Platform. Here we will provide you only interesting content, which you will like very much. We’re dedicated to providing you the best of Blog, with a focus on Crypto, Forex and Stock Market.

Site Map

Our Newsletter

We don’t spam! Read our privacy policy for more info.

© Copyrights. All Rights Reserved 2024 by Tradersnews.org